Abstract
Tumor necrosis factor-α induces oligodendrocytes apoptosis, and is known to stimulate the hydrolysis of sphingomyelin to form the lipid mediator, ceramide. These data encouraged us to determine whether ceramide itself is able to induce apoptosis in oligodendrocytes. For this purpose the cell-permeable ceramide analog, C2-ceramide was used. Treatment of bovine oligodendrocyte cell cultures with this compound induced cell death in a time- and concentration-dependent manner. The induction of cell death was specifically associated with the action of C2-ceramide and could not be elicited by dioctanoylglycerol (DC8) or phorbol 12-myristate 13-acetate (PMA). Treatment of the cultures with neutral sphingomyelinase, which increased the hydrolyses of endogenous sphingomyelin, resulted in oligodendrocyte death, whereas exposure of the cells to phospholipase C and A2 did not. C2-ceramide treatment caused DNA fragmentation. Morphologic analysis of the cells showed that C2-ceramide treatment resulted in a loss of their processes, reduction of cell volume, chromatin condensation, and formation of apoptotic bodies. These results indicate that ceramide can induce oligodendrocyte apoptosis, and suggest that sphingolipid metabolism plays a key role in the regulation of this process.
Similar content being viewed by others
REFERENCES
Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. 1972. Apoptosis: A basic biological phenomenon with wider ranging implications in tissue kinetics. Br. J. Cancer. 24:239–257.
Kerr, J. F. R., Serol, J., Harmon, B. V., and Bishop, C. J. 1987. Apoptosis. Pages 93–128, in C. S. Potten, (ed.) Perspectives on Mammalian Cell Death, Chap. 5 Oxford Science Publications, Oxford and New York.
Wyllie, A. H. 1981. Cell death: a new classification separating apoptosis from necrosis. Pages 3–34, in I. D. Bowen and R. A. Lockshin, (eds.) Cell Death in Biology and Pathology, Chap. 1 Chapman & Hall, London and New York.
Vaux, D. L. 1993. Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA. 90:786–789.
Kimura, K. I., and Truman, J. W. 1990. Postmetamorphic cell death in the nervous and muscular systems of Drosophila melanogaster. J. Neurosci. 10:403–411.
Knapp, P. E., Skoff, R. P., and Redstone, D. W. 1986. Oligodendroglial cell death in jimpy mice: An explanation for the myelin deficit. J. Neurosci. 6:2813–2822.
Cohen, J. J., Duke, R. C., Fado, V. A., and Sellins, K. S. 1992. Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol. 10:267–293.
Hickman, J. A. 1992. Apoptosis induced by anticancer drugs. Cancer Metastisis Rev. 11:121–139.
Laster, S. M., Wood, J. G., and Gooding, L. R. 1988. Target-induced changes in macrophage migration may explain differences in lytic sensitivity among simian virus 40-transformed fibroblasts. J. Immunol. 141:2629–2634.
Heller, R. A., Song, K., Fan, N., and Chang, D. J. 1992. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell. 70:47–56.
Stewart, B. W. 1994. Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J. Nat. Cancer Inst. 86:1287–1296.
Cohen, J. J. 1993. Apoptosis. Immunol. Today. 14:126–130.
Wyllie, A. H. 1995. The genetic regulation of apoptosis. Current Opinion in Genetics and Development. 5:97–104.
Pender, M. P., Nguyen, K. B., McCombe, P. A., and Kerr, J. F. R. 1991. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104:81–87.
Blakemore, W. F. 1972. Observations on oligodendrocyte degeneration, the resolution of statuspongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1:413–426.
Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D., and Raff, M. C. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70:31–46.
Barres, B. A., Schmid, R., Sendnter, M., and Raff, M. C. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 118:283–295.
Selmaj, K., Raine, C. S., Farooq, M., Norton, W. T., and Brosnan, C. F. 1991. Cytokine cytotoxicity against oligodendrocytes. J. Immunol. 147:1522–1529.
Robbins, D. S., Shirazi, Y., Drysdale, B. E., Lieberman, A., Shin, H. S., and Shin, M. L. 1987. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139:2593–2597.
Ruddle, N. H., Bergman, C. M., McGrath, K.M., Lingenheld, E. G., Grunnet, M. L., Padula, J. S., and Clark, R. B. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193–1200.
Lieberman, A. P., Pitha, P. H., Shin, H. S., and Shin, M. L. 1989. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or neurotrophic virus. Proc. Natl. Acad. Sci. USA. 86:6348–6352.
Louis, J. C., Magal, E., Takayama, S., and Varon, S. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science. 259:689–692.
Norton, W. T., and Farooq, M. 1990. Bulk isolation and culture of oligodendroglia from mature brain. Pages 171–178, in Conn, P. M. (ed.), Methods in Neurosci. Vol. 2, Cell culture, Academic Press, Inc., New York, New York.
Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. 1993. Programmed cell death induced by ceramide. Science. 259:1769–1771.
Hakomori, S. 1981. Glycosphingolipids in cellular interaction differentiation, and oncogenesis. Annual Review of Biochemistry. 50:733–764.
Hannun, Y. A., and Bell, R. M. 1989. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 243:500–507.
Hannun, Y. A., Merrill, A. H. Jr., and Bell, R. M. 1991. Use of sphingosine as inhibitor of protein kinase C. Methods in Enzymology. 201:316–328.
Mathias, S., Younes, A., Kan, C. C., Orlow, I., Joseph, C., and Kolesnick, R. M. 1993. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science. 259:519–522.
Okazaki, T., Bielawska, A., Domae, N., Bell, R. M., and Hannun, Y. A. 1994. Characteristics and partial purification of a novel cytosolic, magnesium-independent, neutral sphingomyelinase activated in early signal transduction of 1α,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 269:4070–4077.
Kim, M. Y., Linardic, C., Obeid, L., and Hannun, Y. A. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-Interferon. J. Biol. Chem. 266:484–489.
Okazaki, T., Bielawska, A., Bell, R. M., and Hannun, Y. A. 1990. Role of ceramide as a lipid mediator of 1α,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 265:15823–31.
Dbaibo, G. S., Obeid, L. M., and Hannun, Y. A. 1993. Tumor necrosis factor-α (TNF-α) signal transduction through ceramide. J. Biol. Chem. 268:17762–17766.
Hofman, F. M., Hilton, D. R., Johnson, K., and Merrill, J. E. 1989. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:607–612.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Larocca, J.N., Farooq, M. & Norton, W.T. Induction of Oligodendrocyte Apoptosis by C2-Ceramide. Neurochem Res 22, 529–534 (1997). https://doi.org/10.1023/A:1027332415877
Issue Date:
DOI: https://doi.org/10.1023/A:1027332415877